FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt. The invention also refers to pharmaceutical compositions containing the above citrate, and methods for using citrate in treating several conditions.
EFFECT: what is prepared is the new 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene salt and the pharmaceutical compositions on the basis thereof which can find application in medicine for treating a proliferative disorder.
17 cl, 30 dwg, 5 tbl, 6 ex
| Title |
Year |
Author |
Number |
| 9E-15-(2-PYRROLIDIN-1-YL-ETHOXY)-7,12,25-TRIOXA-19,21,24-TRIAZATETRACYCLO[18.3.1.1(2,5). 1(14,18)]HEXACOSA-1(24),2,4,9,14,16,18(26),20,22-NONAENE CITRATE SALT |
2010 |
- Dajmok Brajan
- Li Chehn' Khsija Andzhelin
- Vil'Jam Ehntoni Deodonija
|
RU2543721C2 |
| NOVEL CRYSTALLINE FORMS OF 1-(4-{[6-AMINO-5-(4-PHENOXY-PHENYL)-PYRIMIDIN-4-YLAMINO]-METHYL}-4-FLUORO-PIPERIDIN-1-YL)-PROPENONE, SALT FORMS THEREOF, AND METHOD OF OBTAINING THEREOF |
2019 |
- Lange Michael
- Kuehn Clemens
- Schlueter Tobias
- Mederski Werner
- Maillard David
- Burini Edoardo
|
RU2836584C2 |
| CRYSTALLINE FORMS OF 3-(2,6-DICHLORO-3,5-DIMETHOXYPHENYL)-1-{ 6-[4-(4-ETHYLPIPERAZIN-1-YL)-PHENYLAMINO]-PYRIMIDIN-4-YL} -1-METHYLUREA AND ITS FRACTIONS |
2010 |
- Jerg Bergkhauzen
- Prasad Kotesvara Kapa
- Dzhozef Makkenna
- Dzhoehl Slejd
- Rejann Vu
- Chzhehnmin Du
- Frank Shtovasser
|
RU2572848C2 |
| NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT |
2004 |
- Blasko Andrej
- Tszin' Tsinvu
- Lu Tsjun'
- Morejdzhis Majkl Ehntoni
- Song Dong
- Vondervell Brenda S'Ju
|
RU2319702C2 |
| PHARMACEUTICAL COMPOSITION OF TRICYCLIC COMPOUND OF DOUBLE INHIBITOR PDE3/PDE4 |
2021 |
- Yan, Myao
- Sun, Yuanyuan
- Li, Vantszin
- Syuj, Chzhun
- Bao, Penyue
- Gao, Tszin
- Dun, Pin
- Khuej, Khuej
- Tszi, Syunfen
- Lo, Yunfu
|
RU2838571C2 |
| (1S,2S,4R)-4-{4-[(1S)-2,3-DIHYDRO-1H-INDEN-1-YLAMINO]-7H-PYRROLO[2,3-d]PYRIMIDIN-7-YL}-2-HYDROXYCYCLOPENTYL)METHYL SULPHAMATE HYDROCHLORIDE |
2010 |
- Armitehjdzh Ian G.
- Chopra Reenu
- Kuper Martin Ian
- Lehngston Mehriann
- Lehngston Stefen P
- Viskochil Stepan
|
RU2562245C2 |
| POLYMORPHIC AND PSEUDOPOLYMORPHIC FORMS OF PHARMACEUTICAL COMPOUND |
2010 |
- Bhattachrya Sisir
- Bonnet Alain
- Dedhiya Mahendra G.
- Ducandas Veronigue
- Giuliani Alexandre
- Priour Alain
- Ravaux Valerie
- Spargo Peter
|
RU2575173C2 |
| POLYMORPHOUS AND PSEUDOPOLYMORPHOUS FORMS OF THE PHARMACEUTICAL COMPOUND |
2010 |
- Bhattacharya Sisir
- Bonnet Alain
- Dedhiya Mahendra G.
- Ducandas Veronique
- Giuliani Alexandre
- Priour Alain
- Ravaux Valerie
- Spargo Peter
|
RU2727509C2 |
| SALT OF ARYLAMINOQUINAZOLINE-CONTAINING COMPOUND AND METHOD FOR PREPARATION AND USE THEREOF |
2021 |
- Zhou Fugang
- He Yuxia
- Zhang Yan
- Lyu Jian
- Shi Kai
- Di Huifeng
- Yang Xinxin
- Sun Jing
|
RU2833198C1 |
| VARIOUS FORMS OF 6-CHLORO-2-ETHYL-N-(4-(4-(4-(TRIFLUOROMETHOXY)PHENYL)PIPERIDIN-1-YL)BENZYL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE |
2019 |
- Nam, Kijyan
- Kim, Dzhesyn
- Chzhun, Chonvon
- Li, Seen
|
RU2826176C2 |
